A detailed history of Truvestments Capital LLC transactions in Sage Therapeutics, Inc. stock. As of the latest transaction made, Truvestments Capital LLC holds 39 shares of SAGE stock, worth $213. This represents 0.0% of its overall portfolio holdings.

Number of Shares
39
Holding current value
$213
% of portfolio
0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$7.02 - $13.08 $273 - $510
39 New
39 $0
Q2 2022

Aug 09, 2022

BUY
$27.52 - $37.99 $1,073 - $1,481
39 New
39 $1,000
Q1 2022

May 02, 2022

SELL
$30.71 - $45.71 $1,197 - $1,782
-39 Closed
0 $0
Q1 2021

May 18, 2021

BUY
$70.65 - $96.76 $2,755 - $3,773
39 New
39 $3,000

Others Institutions Holding SAGE

About Sage Therapeutics, Inc.


  • Ticker SAGE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,422,300
  • Market Cap $326M
  • Description
  • Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...
More about SAGE
Track This Portfolio

Track Truvestments Capital LLC Portfolio

Follow Truvestments Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Truvestments Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Truvestments Capital LLC with notifications on news.